AGPAT2 抗体 (AA 199-278)
Our Local Distributor
北京 101111
Quick Overview for AGPAT2 抗体 (AA 199-278) (ABIN6136640)
抗原
See all AGPAT2 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 199-278
-
序列
- IVPVVYSSFS SFYNTKKKFF TSGTVTVQVL EAIPTSGLTA ADVPALVDTC HRAMRTTFLH ISKTPQENGA TAGSGVQPAQ
-
交叉反应
- 人, 小鼠
-
产品特性
- Polyclonal Antibodies
-
纯化方法
- Affinity purification
-
免疫原
- Recombinant fusion protein containing a sequence corresponding to amino acids 199-278 of human AGPAT2 (NP_006403.2).
-
亚型
- IgG
-
-
-
-
应用备注
- WB,1:500 - 1:2000,IF,1:50 - 1:100
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- AGPAT2 (1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2))
-
别名
- AGPAT2
-
背景
- This gene encodes a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. The protein is located within the endoplasmic reticulum membrane and converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. Mutations in this gene have been associated with congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, a disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.,AGPAT2,1-AGPAT2,BSCL,BSCL1,LPAAB,LPAAT-beta,Cancer,Endocrine & Metabolism,Lipid Metabolism,Cardiovascular,Lipids,Fatty Acids,AGPAT2
-
分子量
- 27 kDa/30 kDa
-
基因ID
- 10555
-
UniProt
- O15120
抗原
-